Viewing StudyNCT00019890

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00019890
Status: COMPLETED
Last Update Posted: 2024-03-04
First Post: 2007-03-02
Brief Title: Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Recurrent Melanoma
Stage IV Melanoma
Stage III Melanoma
Keywords:
Name View
stage melanoma View
adult solid tumor View
body systemsite cancer View
cancer View
melanoma View
recurrent melanoma View
skin tumor View
solid tumor View
stage III melanoma View
stage IV melanoma View